ArticleDiabetology international2020

Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F).

Yuichi Terawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.